Evidence map›Paper›PMID 42018149›Full record

ArticleCancer research2026

Ciliated Cells Drive Critical STING-Mediated Tumor Suppression in the Fallopian Tube Epithelium.

Jose A Colina, Maria Sol Recouvreux, Alexander M Sobeck, Benjamin K Johnson, Yinzhi Lin, Sreeja C Sekhar, Rita A Avelar, Gabriela Rivera-Gonzalez, Yali Zhai, Harini Ram and 21 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Jose A ColinaDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9567-8783
Maria Sol RecouvreuxUniversity of California, Los Angeles, California.ORCID 0000-0002-8064-9381
Alexander M SobeckDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-8490-2631
Benjamin K JohnsonVan Andel Institute , Grand Rapids, Michigan.ORCID 0000-0002-1482-1032
Yinzhi LinDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8968-4327
Sreeja C SekharDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0005-3229-2671
Rita A AvelarDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-4574-3046
Gabriela Rivera-GonzalezDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0007-0738-2282
Yali ZhaiDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0000-5399-6137
Harini RamDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0002-5936-4565
Amber FatimaDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0009-9739-4424
Paula DiBenedettoDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0004-6996-1931
Justin BaldassarreDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0004-0745-9268
Grace McIntyreDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-1034-9997
Jessica TeitelDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8962-4690
Michele L DziubinskiDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.
Noah PuleoDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5858-393X
Jane MigloUniversity of Illinois Chicago , Chicago, Illinois.ORCID 0009-0005-5517-9858
Karan BediDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-7843-738X
Hui ShenVan Andel Institute , Grand Rapids, Michigan.ORCID 0000-0001-9767-4084
Dafydd ThomasDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-0379-7460
Jutta HuvilaUniversity of Turku , Turku, Finland.ORCID 0000-0002-2685-0877
Dawn R CochraneBritish Columbia Cancer Research Centre, Vancouver, Canada.ORCID 0000-0002-1523-9351
Ronny DrapkinUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-6912-6977
Yu L LeiUniversity of Texas MD Anderson Cancer Center , Houston, Texas.ORCID 0000-0002-9868-9824
Joanna E BurdetteUniversity of Illinois Chicago , Chicago, Illinois.ORCID 0000-0002-7271-6847
Stephanie L SkalaDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5631-5381
David G HuntsmanBritish Columbia Cancer Research Centre, Vancouver, Canada.ORCID 0000-0003-4934-3322
Kathleen R ChoDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0500-9998
Sandra OrsulicUniversity of California, Los Angeles, California.ORCID 0000-0001-5119-8721
Analisa DiFeoDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-8319-6763

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
Microfluidic Models of Ovarian Cancer Preneoplastic LesionsR01CA240301 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Joanna E Burdette, Jonathan Coppeta · 2019 to 2026
$4.6M
Restoring the Immunogenicity of Head and Neck CancerR01DE026728 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Yu Leo Lei, James J. Moon · 2018 to 2026
$4.3M
Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancerR01CA197780 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Analisa Virginia DiFeo · 2016 to 2026
$3.3M
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in MiceR01CA226756 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHO, KATHLEEN R. · 2019 to 2023
$2.6M
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasisR01CA240423 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BURDETTE, JOANNA E, SANCHEZ, LAURA MARGARET · 2020 to 2024
$2.1M
BLRD VA I01 BX004974BLRD VA I01 BX006020Honorable Tina Brozman Foundation (TW) Rising Star FellowshipNational Cancer Institute (NCI) 2T32CA009676-31National Cancer Institute (NCI) CA240301National Cancer Institute (NCI) CA240423National Cancer Institute (NCI) DE026728National Cancer Institute (NCI) R01CA197780National Cancer Institute (NCI) R01CA226756National Center for Advancing Translational Sciences (NCATS) UL1TR001881NCATS NIH HHS UL1 TR001881NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA197780NCI NIH HHS R01 CA226756NCI NIH HHS R01 CA240301NCI NIH HHS R01 CA240423NCI NIH HHS T32 CA009676NIDCR NIH HHS R01 DE026728U.S. Department of Defense (DOD) HT9425-24-1-0193U.S. Department of Defense (DOD) W81XWH-22-1-0631U.S. Department of Defense (DOD) W81XWH-22-1-0852U.S. Department of Veterans Affairs (VA) VA-ORD BX004974U.S. Department of Veterans Affairs (VA) VA-ORD BX006020
6 · The paper itself

Abstract

Mitigating DNA damage in the fallopian tube epithelium (FTE) is essential for preventing tubo-ovarian high-grade serous carcinoma (HGSC). In this study, we demonstrated that the stimulator of interferon genes (STING) is abundantly expressed in the ciliated cells of the FTE and functions as a critical immune-independent tumor suppressor. In patient samples, mouse models, and organoid systems, ciliated cells mounted a dual protective response to ovulation-associated genotoxic stress: intrinsic STING-driven apoptosis and extrinsic clearance of neighboring damaged secretory cells via TNFα secretion. This surveillance mechanism markedly limited DNA damage accumulation within the epithelial microenvironment. Crucially, although these mechanisms were vital for maintaining homeostasis and reducing genomic instability, they failed to affect p53-deficient precursor lesions as both the intrinsic and extrinsic proapoptotic processes relied on functional p53 signaling. These findings redefine ciliated cells as key gatekeepers of genome integrity rather than passive bystanders and implicate the early loss of STING-high ciliated cells as a pivotal event in HGSC initiation. SIGNIFICANCE: STING-high ciliated fallopian tube cells function as immune-independent active guardians of genomic integrity whose loss creates a permissive niche for high-grade serous carcinoma initiation, which could inform prevention and treatment strategies.

Indexed as

CiliaFallopian Tube NeoplasmsFallopian TubesMembrane ProteinsAnimalsApoptosisDNA DamageEpithelial CellsEpitheliumFemaleHumansMiceSignal TransductionSTING ProteinTumor Suppressor Protein p53Membrane ProteinsSTING1 protein, humanSting1 protein, mouseSTING ProteinTumor Suppressor Protein p53

Identifiers

PMID42018149
PMCPMC13105266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.